Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes)
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes)
Authors
Keywords
-
Journal
BIOCHEMICAL SOCIETY TRANSACTIONS
Volume 41, Issue 1, Pages 245-251
Publisher
Portland Press Ltd.
Online
2013-01-29
DOI
10.1042/bst20120265
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human Tumor-Derived Exosomes Down-Modulate NKG2D Expression
- (2014) A. Clayton et al. JOURNAL OF IMMUNOLOGY
- CSPG4 as a Target of Antibody-Based Immunotherapy for Malignant Mesothelioma
- (2012) Z. Rivera et al. CLINICAL CANCER RESEARCH
- Plasma-derived MHC class II+ exosomes from tumor-bearing mice suppress tumor antigen-specific immune responses
- (2012) Chenjie Yang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Melanoma exosomes: messengers of metastasis
- (2012) Rajasekharan Somasundaram et al. NATURE MEDICINE
- Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
- (2012) Héctor Peinado et al. NATURE MEDICINE
- Exosomes as intercellular signalosomes and pharmacological effectors
- (2011) Michel Record et al. BIOCHEMICAL PHARMACOLOGY
- Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor- 1
- (2011) M. J. Szczepanski et al. HAEMATOLOGICA
- Cancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production
- (2011) A. Clayton et al. JOURNAL OF IMMUNOLOGY
- Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments
- (2011) Douglas D. Taylor et al. Seminars in Immunopathology
- Mechanisms of T-cell protection from death by IRX-2: a new immunotherapeutic
- (2010) Malgorzata Czystowska et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Myeloid-Derived Suppressor Cells in Human Cancer
- (2010) Srinivas Nagaraj et al. CANCER JOURNAL
- CD73: A Novel Target for Cancer Immunotherapy
- (2010) B. Zhang CANCER RESEARCH
- Adenosine and Prostaglandin E2Cooperate in the Suppression of Immune Responses Mediated by Adaptive Regulatory T Cells
- (2010) Magis Mandapathil et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tumor-Derived Microvesicles Induce, Expand and Up-Regulate Biological Activities of Human Regulatory T Cells (Treg)
- (2010) Marta Szajnik et al. PLoS One
- Exosomes: immune properties and potential clinical implementations
- (2010) Nathalie Chaput et al. Seminars in Immunopathology
- Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors
- (2009) Miroslaw J. Szczepanski et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death
- (2009) M Czystowska et al. CELL DEATH AND DIFFERENTIATION
- Tumor-Derived Microvesicles Promote Regulatory T Cell Expansion and Induce Apoptosis in Tumor-Reactive Activated CD8+ T Lymphocytes
- (2009) E. U. Wieckowski et al. JOURNAL OF IMMUNOLOGY
- Shedding microvesicles: artefacts no more
- (2009) Emanuele Cocucci et al. TRENDS IN CELL BIOLOGY
- Tumor-derived microvesicles in sera of patients with head and neck cancer and their role in tumor progression
- (2008) Christoph Bergmann et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- More insights into the immunosuppressive potential of tumor exosomes
- (2008) Veronica Huber et al. Journal of Translational Medicine
- Exosomes as a tumor immune escape mechanism: possible therapeutic implications
- (2008) Thomas E Ichim et al. Journal of Translational Medicine
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started